Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
for
Hematuria - Cause Not Known
Location: New York NY, Poughkeepsie NY, Albany NY,
Sponsor: Pacific Edge Limited
Sex: All
Age: 18 - 70+
Code: NCT06394869
Recruiting
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
for
Adenovirus, Primary Immune Deficiency Disorder
Location: Philadelphia PA, Columbus OH, Indianapolis IN,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266627
Phase 2, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Halifax, Boston MA, Quebec, New York NY, Hackensack NJ,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase 2, Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
for
Atrial Fibrillation (AF)
Location: Halifax, Great Neck NY, Philadelphia PA, Ottawa,
Sponsor: McMaster University
Sex: All
Age: 18 - 70+
Code: NCT06844227
Recruiting
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
for
Healthy Participants, Hemophilia A, Hemophilia B,
Location: Philadelphia PA, Hershey PA, Hamilton, Ann Arbor MI,
Sponsor: Equilibra Bioscience LLC
Sex: All
Age: 18 - 60
Code: NCT06349473
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)